研究目的
To evaluate the efficacy and complications of intra-arterial chemotherapy (IAC) for retinoblastoma using magnetic resonance imaging (MRI).
研究成果
MRI is a reliable diagnostic approach to evaluate the activity of residual tumor foci after IAC, to monitor the risk factors of optic nerve invasion, extraocular invasion, recurrence, and metastasis, and to follow the associated complications of IAC. MRI could be used to monitor the risk factor of abnormal enhancement of the postlaminar optic nerve, thus avoiding unnecessary enucleation.
研究不足
The study was limited by its retrospective nature and the relatively short follow-up period for some patients. Additionally, the sample size may not be sufficient to generalize the findings to all retinoblastoma patients.
1:Experimental Design and Method Selection:
Retrospective analysis of MRI features of 60 patients with unilateral retinoblastoma treated with IAC.
2:Sample Selection and Data Sources:
Patients selected from 202 retinoblastoma patients treated and followed up between January 2014 and February
3:List of Experimental Equipment and Materials:
20 3.0-T MR scanner (SignaHdx; GE Medical Systems, Milwaukee, WI, USA) with an eight-channel head coil.
4:0-T MR scanner (SignaHdx; GE Medical Systems, Milwaukee, WI, USA) with an eight-channel head coil. Experimental Procedures and Operational Workflow:
4. Experimental Procedures and Operational Workflow: MRI performed under patient sedation, including nonenhanced T1-weighted spin-echo images, T2-weighted fast spin-echo images, axial contrast-enhanced T1-weighted images with fat saturation, and DWI.
5:Data Analysis Methods:
Statistical analysis performed with SPSS software package, version 18.0, using paired samples t-tests and independent sample t-tests.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容